Evidence map›Paper›PMID 37497317›Full record

ArticleOpen respiratory archives

Risk Factors of Mortality in Hospitalized Patients With COVID-19 Applying a Machine Learning Algorithm.

Irene Nieto-Codesido, Uxio Calvo-Alvarez, Carmen Diego, Z Hammouri, Narmeen Mallah, María José Ginzo-Villamayor, Francisco Javier Salgado, José Martín Carreira, Carlos Rábade, Gema Barbeito and 2 more

Abstract read
In one paragraph

Article in Open respiratory archives. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Irene Nieto-CodesidoDepartment of Respiratory Medicine, University Hospital of Ferrol, Spain.
Uxio Calvo-AlvarezDepartment of Respiratory Medicine, University Hospital of Ferrol, Spain.
Carmen DiegoDepartment of Respiratory Medicine, University Hospital of Ferrol, Spain.
Z HammouriUniversity of Santiago de Compostela, Spain.
Narmeen MallahDepartment of Psychiatry, Radiology, Public Health, Nursery and Medicine, Universidad de Santiago de Compostela, Spain.
María José Ginzo-VillamayorDepartamento de Estadística, Análisis Matemático y Optimización, Facultad de Matemáticas, Universidad de Santiago de Compostela, Spain.
Francisco Javier SalgadoDepartment of Biochemistry and Molecular Biology, Faculty of Biology-Biological Research Centre (CIBUS), Universidade de Santiago de Compostela, Spain.
José Martín CarreiraDepartment of Psychiatry, Radiology, Public Health, Nursery and Medicine, Universidad de Santiago de Compostela, Spain.
Carlos RábadeDepartment of Respiratory Medicine, University Hospital of Santiago de Compostela, Spain.
Gema BarbeitoMicrobiology Department, University Hospital of Santiago de Compostela, Spain.
Miguel Ángel Gonzalez-PerezCentro de Salud Valle-Inclán, Orense, Spain.
Francisco Javier Gonzalez-BarcalaDepartment of Psychiatry, Radiology, Public Health, Nursery and Medicine, Universidad de Santiago de Compostela, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Risk stratification of patients with COVID-19 can be fundamental to support clinical decision-making and optimize resources. The objective of our study is to identify among the routinely tested clinical and analytical parameters those that would allow us to determine patients with the highest risk of dying from COVID-19. Material and methods: We carried out a retrospective cohort multicentric study by consecutively, including hospitalized patients with COVID-19 admitted in any of the 11 hospitals in the healthcare network of HM Hospitals-Spain. We collected the clinical, demographic, analytical, and radiological data from the patient's medical records.To assess each of the biomarkers' predictive impact and measure the statistical significance of the variables involved in the analysis, we applied a random forest with a permutation method. We used the similarity measure induced by a previously classification model and adjusted the k-groups clustering algorithm based on the energy distance to stratify patients into a high and low-risk group. Finally, we adjusted two optimal classification trees to have a schematic representation of the cut-off points. Results: We included 1246 patients (average age of 65.36 years, 62% males). During the study one hundred sixty-eight patients (13%) died. High values of age, D-Dimer, White Blood Cell, Na, CRP, and creatinine represent the factors that identify high-risk patients who would die. Conclusions: Age seems to be the primary predictor of mortality in patients with SARS-CoV-2 infection, while the impact of acute phase reactants and blood cellularity is also highly relevant.

Indexed as

AgeGenderMachine learningPrognosisSeverity

Identifiers

PMID37497317
PMCPMC8818319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.